Encapsulation of nucleic acids and opportunities for cancer treatment

  • Brannon-Peppas L
  • Ghosn B
  • Roy K
 et al. 
  • 25


    Mendeley users who have this article in their library.
  • 25


    Citations of this article.


The development of nucleic acid drugs for the treatment of various cancers has shown great promise in recent years. However, efficient delivery of these drugs to target cells remains a significant challenge towards the successful development of such therapies. This review provides a comprehensive overview of encapsulation technologies being developed for the delivery of nucleic acid-based anti-cancer agents. Both micro and nanoparticles systems are discussed along with their use in delivering plasmid DNA as well as oligonucleotides. The majority of the systems discussed have used DNA immunotherapy as the potential mode of anticancer therapy, which requires targeting to antigen presenting cells. Other applications, including those with oligonucleotides, focus on targeting tumor cells directly. The results obtained so far show the excellent promise of encapsulation as an efficient means of delivering therapeutic nucleic acids.

Author-supplied keywords

  • Cancer
  • DNA
  • Encapsulation
  • Gene
  • Particles

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Lisa Brannon-Peppas

  • Bilal Ghosn

  • Krishnendu Roy

  • Kenneth Cornetta

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free